Traditional Chinese medicine in the era of immune checkpoint inhibitor: theory, development, and future directions
Abstract Immune checkpoint inhibitors (ICIs) have revolutionized cancer management and have been widely applied; however, they still have some limitations in terms of efficacy and toxicity. There are multiple treatment regimens in Traditional Chinese Medicine (TCM) that play active roles in combinat...
Saved in:
Main Authors: | Yi-xuan Yu (Author), Shuo Wang (Author), Zhe-ning Liu (Author), Xu Zhang (Author), Zi-xin Hu (Author), Hui-jing Dong (Author), Xing-yu Lu (Author), Jia-bin Zheng (Author), Hui-juan Cui (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors
by: Florian Huemer, et al.
Published: (2021) -
Immune checkpoint inhibitor-induced acute tubulointerstitial nephritis
by: Hui Zhuan Tan, et al.
Published: (2022) -
The Strategies and Mechanisms of Immune Checkpoint Inhibitors for Brain Metastases in NSCLC
by: Ji Li, et al.
Published: (2022) -
Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma
by: Albert Jang, et al.
Published: (2023) -
Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
by: Rilan Bai, et al.
Published: (2020)